| Home | About Natural News | Contact Us | Write for Natural News | Media Information | Advertise with Natural News | ||||
![]() |
![]() |
|||
|
||||
|
|
The 2009 review examined 40 separate international studies which compared the effect of P-6 with a placebo in treating nausea and vomiting after surgery. The studies, which totaled 4,858 patients, used ten different methods of P-6 stimulation, including needle acupuncture, laser stimulation, transcutaneous nerve stimulation and acupressure wristbands. The review found that in comparison with a placebo, stimulating acupoint P-6 reduced nausea, vomiting and the need for conventional antiemetic (anti-nausea) drugs. It concluded, "The use of P-6 acupoint stimulation can reduce the risk of nausea and vomiting after surgery, with minimal side effects." "In head-to-head comparisons with antiemetics," commented Dr. Anne Lee, "P-6 stimulation was as good at reducing the risk of postoperative nausea and vomiting." Based on the findings, Dr. Lee asserts that "P-6 acupoint stimulation can be used as a suitable alternative or an addition to antiemetic therapy before, during or after surgery." Acupoint P-6 Acupoint P-6 is located on the inside of either forearm, approximately 2 inches down from the crease of your wrist and between the tendons palmaris longus and flexor carpi radialis. In order to find the point, make a fist and curl it inwards. You should be able to see the two tendons protruding from the inside of your forearm. To be accurate, the point is located one sixth of the way from your wrist crease to the crease on the inside of your elbow (cubital crease). To manually stimulate P-6, locate the point, relax your arm and then press your thumb between the tendons down into the point until it feels quite tender. Hold it down firmly from 30 seconds to 2 minutes and then try the other arm. Of all the acupoints on the human body, this point is a very popular choice for study because of the mounting costs of conventional antiemetic drugs and the point's distinguished and internationally-affirmed history of treating the symptoms of nausea and vomiting. The Cochrane Collaboration This international not-for-profit and independent organization is dedicated to disseminating cutting-edge and accurate information regarding all medical and healthcare findings. Considered to be the top source for up-to-date medical information, The Cochrane Collaboration currently has fifteen centres worldwide supporting fifty specialist Collaborative Review Groups (CRGs). Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing trials on a topic. Sources 1) http://www.cfah.org/hbns/archives/v... 2) http://www.sciencedaily.com/release... 3) http://www.news-medical.net/?id=48354 4) http://www.ncbi.nlm.nih.gov/pubmed/... The following is reference material on other P-6 studies organized by country of origin. Canada 1) 2005: Double-blind study (60 patients) http://www.cja-jca.org/cgi/content/... 2) 2003: Double-blind study http://www.cja-jca.org/cgi/content/... 3) 2002: Double-blind study (150 patients) http://www.cja-jca.org/cgi/content/... Britain 1) 2009: Placebo-controlled study (200 patients) http://bja.oxfordjournals.org/cgi/c... 2) 2006: Randomised-controlled trial (36 patients) http://www.sciencedirect.com/scienc... USA 1) 2009: Randomised clinical trial (88 patients) http://www.ncbi.nlm.nih.gov/pubmed/... 2) 2006: Meta-Analysis (26 trials) http://www.ncbi.nlm.nih.gov/pubmed/... 3) 2006: Meta-Analysis (12 trials) http://www.ncbi.nlm.nih.gov/pubmed/... 4) 2006: Meta-analysis (33 studies) http://www.ncbi.nlm.nih.gov/pubmed/... 5) 2006: Meta-Analysis (11 trials) http://www.ncbi.nlm.nih.gov/pubmed/... 6) 2005: Meta-Analysis (11 trials) http://www.ncbi.nlm.nih.gov/pubmed/... 7) 2002: Placebo-controlled study (187 subjects) http://www.ncbi.nlm.nih.gov/pubmed/... 8) 2002: Review http://pt.wkhealth.com/pt/re/ajog/a... 9) 2002: Double-blind study (120 patients) http://www.ncbi.nlm.nih.gov/pubmed/... 10) 2001: Double-blind study (221 patients) http://www.ncbi.nlm.nih.gov/pubmed/... Sweden 1) 2002: Double-blind study (410 patients) http://www.ncbi.nlm.nih.gov/pubmed/... 2) 2001: Placebo-controlled study (60 patients) http://www.ncbi.nlm.nih.gov/pubmed/... 3) 1999: Double-blind (60 patients) http://www.ncbi.nlm.nih.gov/pubmed/... 4) 1999: Double-blind (60 patients) http://www.ncbi.nlm.nih.gov/pubmed/... Italy 1) 2007: Clinical trial (100 patients) http://www.ncbi.nlm.nih.gov/pubmed/... Germany 1) 2009: Randomised-controlled trial (200 patients) http://www.ncbi.nlm.nih.gov/pubmed/... Switzerland 1) 2007: Double-blind study (220 patients) http://www.ncbi.nlm.nih.gov/pubmed/... Austria 1) 2002: Double-blind study (80 patients) http://www.anesthesia-analgesia.org... 2) 1998: Double-blind study http://bja.oxfordjournals.org/cgi/c... Turkey 1) 2008: Placebo-controlled (75 patients) http://www.ncbi.nlm.nih.gov/pubmed/... Korea 1) 2002: Double-blind study (160 patients) http://www.ncbi.nlm.nih.gov/pubmed/...
About the authorDave Gabriele, R.Ac, is a registered acupuncturist helping people in the Greater Toronto Area (Ontario, Canada). He has been a practitioner and a teacher of Chinese martialarts since 1997. In 2006, he received a B.A. from York University and he is currently studying at TSTCM to become a doctor of Traditional Chinese Medicine. Related CounterThink Cartoons:
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Home | About Natural News | Contact Us | Write for Natural News | Media Information | Advertise with Natural News This site is part of the Natural News Network © 2009 All Rights Reserved. Privacy | Terms All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing International, LTD. is not responsible for content written by contributing authors. The information on this site is provided for educational and entertainment purposes only. It is not intended as a substitute for professional advice of any kind. Truth Publishing assumes no responsibility for the use or misuse of this material. Your use of this website indicates your agreement to these terms and those published here. All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners. |
![]() |